14-95093976-T-C
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 1P and 5B. BS2BP4PM1_Supporting
This summary comes from the ClinGen Evidence Repository: The NM_177438.2:c.5276A>G variant in DICER1 is a missense variant predicted to cause substitution of Lysine by Arginine at amino acid 1759 (p.Lys1759Arg). The highest population minor allele frequency in gnomAD v2.1.1 is 0.0001071 in European (non-Finnish) population (PM2_Supporting, BS1, and BA1 are not met). This variant has been seen in 40 or more unrelated females without tumors through age 50 in at least one testing laboratory (BS2; Internal lab contributors: 61756, 500031). The computational predictor REVEL gives a score of 0.444, which is below the threshold of 0.5, and the splice site predictors MaxEntScan and SpliceAI indicate that the variant has no impact on splicing, evidence that does not predict a damaging effect on DICER1 function (BP4). This variant resides within the RNase IIIb domain of DICER1, that is defined as a mutational hotspot and critical functional domain by the ClinGen DICER1 VCEP (PMID:31342592)(PM1_Supporting). In summary, this variant meets the criteria to be classified as Likely Benign for DICER1 syndrome. Although there are both pathogenic and benign types of evidence for this variant, the pathogenic evidence is not considered inconsistent with the final classification. ACMG/AMP criteria applied, as specified by the ClinGen DICER1 VCEP: (BS2, BP4, PM1_Supporting). (Bayesian Points: -4; VCEP specifications version 1; 02/11/2022). LINK:https://erepo.genome.network/evrepo/ui/classification/CA158282/MONDO:0017288/024
Frequency
Consequence
NM_177438.3 missense
Scores
Clinical Significance
Conservation
Publications
- DICER1-related tumor predispositionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- pleuropulmonary blastomaInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- DICER1 syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- global developmental delay - lung cysts - overgrowth - Wilms tumor syndromeInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_177438.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DICER1 | MANE Select | c.5276A>G | p.Lys1759Arg | missense | Exon 24 of 27 | NP_803187.1 | Q9UPY3-1 | ||
| DICER1 | c.5276A>G | p.Lys1759Arg | missense | Exon 24 of 27 | NP_001258211.1 | Q9UPY3-1 | |||
| DICER1 | c.5276A>G | p.Lys1759Arg | missense | Exon 24 of 27 | NP_001278557.1 | Q9UPY3-1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DICER1 | TSL:1 MANE Select | c.5276A>G | p.Lys1759Arg | missense | Exon 24 of 27 | ENSP00000343745.3 | Q9UPY3-1 | ||
| DICER1 | TSL:1 | c.5276A>G | p.Lys1759Arg | missense | Exon 26 of 29 | ENSP00000376783.1 | Q9UPY3-1 | ||
| DICER1 | TSL:1 | c.5276A>G | p.Lys1759Arg | missense | Exon 24 of 27 | ENSP00000435681.1 | Q9UPY3-1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152144Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000557 AC: 14AN: 251452 AF XY: 0.0000515 show subpopulations
GnomAD4 exome AF: 0.0000554 AC: 81AN: 1461858Hom.: 0 Cov.: 32 AF XY: 0.0000550 AC XY: 40AN XY: 727234 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152144Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74300 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at